Young Matthew P.
Reporting Owner SEC Filing List
CIK: 0001601583
| Form | Filer | Subject Company | Filing Agent | Date | Actions | ||
|---|---|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Cytomx Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 06/22/2026 | |||
| 4 | Statement of changes in beneficial owner... | Young Matthew P. | 06/22/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Cytomx Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 06/13/2025 | |||
| 4 | Statement of changes in beneficial owner... | Young Matthew P. | Latham & Watkins Llp (filing Agent) /fa | 06/13/2025 | |||
| 4 | Statement of changes in beneficial owner... | Cytomx Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 05/17/2024 | |||
| 4 | Statement of changes in beneficial owner... | Young Matthew P. | Latham & Watkins Llp (filing Agent) /fa | 05/17/2024 | |||
| 4 | Statement of changes in beneficial owner... | Young Matthew P. | Latham & Watkins Llp (filing Agent) /fa | 06/16/2023 | |||
| 4 | Statement of changes in beneficial owner... | Cytomx Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 06/16/2023 | |||
| 4 | Statement of changes in beneficial owner... | Young Matthew P. | Latham & Watkins Llp (filing Agent) /fa | 06/16/2023 | |||
| 4 | Statement of changes in beneficial owner... | Cytomx Therapeutics, Inc. | Broadridge Financial Solutions, Inc./fa | 06/17/2022 | |||
| Load More | |||||||
Young Matthew P. 's Ownership Transactions
| Issuer | Filing Date |
Transaction Date |
Transaction Type |
Shares | Price | Total Amt | Shares Owned |
|---|
